At the young age of 19, Elizabeth Holmes founded her revolutionary blood diagnostic company called Theranos while dropping out of college to follow her dream. She knew exactly what she wanted to do and when she wanted to start it. In the fall of 2003, as a sophomore at Stanford, while sitting down in the office of her chemical engineering professor, Channing Robertson, Elizabeth Holmes said, “Let’s start a company.”
Robertson has seen thousands of students over his long career want to create companies. “I knew she was different,” Robertson told me in an interview. “The novelty of how she would view a complex technical problem–it was unique in my experience.”
Robertson said, ‘Why do you want to do this?’ And she said, ‘Because systems like this could completely revolutionize how effective health care is delivered. And this is what I want to do. I don’t want to make an incremental change in some technology in my life. I want to create a whole new technology, and one that is aimed at helping humanity at all levels regardless of geography or ethnicity or age or gender.’ ”
“When I finally connected with what Elizabeth fundamentally is,” he says, “I realized that I could have just as well been looking into the eyes of a Steve Jobs or a Bill Gates.”
Fast Forward 11 years later, Theranos is a potentially highly disruptive upstart in America’s $73 billion diagnostic-lab industry, which performs nearly 10 billion tests a year and is estimated to provide the basis for about 70% of doctors’ medical decisions. Medicare and Medicaid each pay roughly $10 billion annually on reimbursements for these tests.
Please look more into Theranos by visiting their website http://www.Theranos.com